ESG

Specialized Packaging Group's new 75,000-sq-ft Austin plant brings advanced manufacturing and sustainable solutions to the region's booming industries.

A new partnership highlights how specialized tech is becoming essential for navigating complex IRA tax rules, de-risking billions in renewable energy projects.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

With a new unified command under mining veteran Mark Wall, American Rare Earths aims to accelerate its massive Halleck Creek project and secure the U.S. supply chain.

As the spring market heats up, learn how strategic landscaping and simple maintenance can yield over 200% ROI and make your home irresistible to buyers.

A new study reveals a massive shift in perception, with pro gaming now a top career choice for Gen Z, backed by a multi-billion dollar industry.

A new partnership brings advanced, non-invasive Alzheimer's blood tests to community centers, aiming for mass early detection and reshaping diagnostics.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

Lorissa's Organic Snacks expands with certified allergen-free options, but a look at the market reveals a competitive race for consumer trust and safety.

With its sixth deal of 2026, WhiteHawk expands its footprint in the Haynesville Shale, tying its fortunes to the booming but controversial U.S. LNG market.

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

For millions suffering from relentless chronic cough with no approved treatments, Trevi Therapeutics' Haduvio offers a new possibility backed by strong clinical data.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

Amid soaring uranium prices, Refined Energy begins its maiden drill program in Saskatchewan's prolific Athabasca Basin, a high-stakes bet on nuclear's future.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

Total Joint Orthopedics surpasses 50,000 implants, signaling a major shift as surgeries move from hospitals to efficient, cost-effective surgery centers.

Riding high on U.S. success, GEEK BAR returns to Europe with a reusable vape, a strategic pivot as the continent wages war on disposable products.

McFarlane Lake Mining's latest drill results reveal a massive 95.4-meter gold intersection, signaling a major expansion of its Juby gold project.

Private equity giant Warburg Pincus invests up to $1 billion in Global Eggs, fueling a rapid consolidation of the world's protein supply.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.